Completed NA INTERVENTIONAL 1-arm NCT05658588

Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock (PedCyto)

Impact of Cytosorb and CKRT on Hemodynamics in Pediatric Patients With Septic Shock: the PedCyto Study

Sponsor: Ospedale Pediatrico Bambin Gesù

Interventions Cytosorb

Updated 3 times since 2023 Last updated: Dec 13, 2022 Started: Sep 1, 2019 Primary completion: Oct 1, 2021 Completion: Oct 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Septic Shock and is currently completed. Ospedale Pediatrico Bambin Gesù leads this study, which shows 3 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ospedale Pediatrico Bambin Gesù

Data source: Ospedale Pediatrico Bambin Gesù

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy